CAS No. | 57-85-2 |
Appearance | White powder |
propionate is a slower releasing with a short half-life. This characteristic allows the user to run short propionate cycles of 8-10 weeks as optimal peak blood plasma levels are achieved at 2-4 weeks.It is a synthetic androstane derivative of in the form of 17β propionate ester of . propionate was developed initially by Watson labs, and FDA approved on February 5, 1974. Currently, this drug has been discontinued in humans, but the vet application is still available as an OTC.